Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aytu Biopharma (AYTU) Non Operating Investment Income (2016 - 2017)

Aytu Biopharma (AYTU) has disclosed Non Operating Investment Income for 2 consecutive years, with -$292455.0 as the latest value for Q2 2017.

  • On a quarterly basis, Non Operating Investment Income changed N/A to -$292455.0 in Q2 2017 year-over-year; TTM through Jun 2017 was -$61519.0, a N/A change, with the full-year FY2017 number at -$61519.0, up 93.67% from a year prior.
  • Non Operating Investment Income was -$292455.0 for Q2 2017 at Aytu Biopharma, up from -$497164.0 in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $728100.0 in Q3 2016 to a low of -$497164.0 in Q4 2016.